Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Roselle flower extracts can protect against free radical damage in UV-irradiated antibiotics.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Inclisiran is effective at lowering cholesterol.

The nanoplatform helps heal wounds by balancing bacteria-killing and inflammation-reducing functions.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.